New technologies for the control of human hookworm infection

Trends in Parasitology

Volumn 22, Issue 7, 2006, Pages 327-331

  Hotez, Peter J ^a,b   Bethony, Jeff ^a   Bottazzi, Maria Elena ^a   Brooker, Simon ^c   Diemert, David ^b   Loukas, Alex ^d  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b SABIN VACCINE INSTITUTE   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ALUMINUM HYDROXIDE; ANCYLOSTOMA SECRETED PROTEIN 1; ANCYLOSTOMA SECRETED PROTEIN 2; ANTHELMINTIC AGENT; BENZIMIDAZOLE; MEBENDAZOLE; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; TIABENDAZOLE; TRIBENDIMIDINE; UNCLASSIFIED DRUG;

CLINICAL TRIAL; DRUG EFFICACY; FEASIBILITY STUDY; HEALTH PROGRAM; HOOKWORM INFECTION; HUMAN; INFECTION CONTROL; MORBIDITY; REVIEW; TECHNOLOGY; TROPICAL DISEASE;

ANCYLOSTOMATOIDEA; ANIMALS; ANTHELMINTICS; DRUG DESIGN; HOOKWORM INFECTIONS; HUMANS; VACCINES, SYNTHETIC;

ANCYLOSTOMATOIDEA;

EID: 33745405943     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2006.05.004     Document Type: Review

References (64)

1. Brooker S., et al. Human hookworm infection in the 21st century. Adv. Parasitol. 58 (2004) 197-288
2. Bungiro R., and Cappello M. Hookworm infection: new developments and prospects for control. Curr. Opin. Infect. Dis. 17 (2004) 421-426
3. Bethony J., et al. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet 367 (2006) 1521-1532
4. de Silva N.R., et al. Soil-transmitted helminth infections: updating the global picture. Trends Parasitol. 19 (2003) 547-551
5. Hotez P.J. China's hookworms. China Q. 172 (2002) 1029-1041
6. Xu L.-Q., et al. Soil-transmitted helminthiases: nationwide survey in China. Bull. World Health Organ. 73 (1995) 507-513
7. National Institute of Parasitic Diseases, China CDC (2005) Report on the National Survey of Current Situation of Major Human Parasitic Diseases in China. Ministry of Health, P.R. China.
8. Stoltzfus R.J., et al. Hookworm control as a strategy to prevent iron deficiency. Nutr. Rev. 55 (1997) 223-232
9. Moraes L.R., et al. Impact of drainage and sewerage on intestinal nematode infections in poor urban areas in Salvador, Brazil. Trans. R. Soc. Trop. Med. Hyg. 98 (2004) 197-204
10. Anderson R.M., and May R.M. Population dynamics of human helminth infections: control by chemotherapy. Nature 297 (1982) 557-563
11. Bundy D.A.P. Population ecology of intestinal helminth infections in human communities. Philos. Trans. R. Soc. Lond. B Biol. Sci. 321 (1988) 405-420
12. Bundy D.A., et al. Control of geohelminths by delivery of targeted chemotherapy through schools. Trans. R. Soc. Trop. Med. Hyg. 84 (1990) 115-120
13. Partnership for Child Development (1997) Better health, nutrition and education for the school-aged child. Trans. R. Soc. Trop. Med. Hyg. 91, 1-2
14. Stephenson L.S., et al. Treatment with a single dose of albendazole improves growth of Kenyan schoolchildren with hookworm, Trichuris trichiura, and Ascaris lumbricoides infections. Am. J. Trop. Med. Hyg. 41 (1989) 78-87
15. Stephenson L.S., et al. Improvements in physical fitness of Kenyan schoolboys infected with hookworm, Trichuris trichiura and Ascaris lumbricoides following a single dose of albendazole. Trans. R. Soc. Trop. Med. Hyg. 84 (1990) 277-282
16. Sakti H., et al. Evidence for an association between hookworm infection and cognitive function in Indonesia school children. Trop. Med. Int. Health 4 (1999) 322-334
17. World Bank (2003) School deworming at a glance. http://siteresources.worldbank.org/INTPHAAG/Resources/AAGDewormingEng110603.pdf
18. Bhargava A., et al. Anthelmintic treatment improves the hemoglobin and serum ferritin concentrations of Tanzanian schoolchildren. Food Nutr. Bull. 24 (2003) 332-342
19. Stoltzfus R.J., et al. Low dose daily iron supplementation improves iron status and appetite, but not anemia, whereas quarterly anthelminthic treatment improves growth, appetite and anemia in Zanzibari preschool children. J. Nutr. 134 (2004) 348-356
20. Brooker S., et al. The epidemiology of hookworm infection and its contribution to anaemia among pre-school children on the Kenyan coast. Trans. R. Soc. Trop. Med. Hyg. 93 (1999) 240-246
21. Bundy D.A., et al. Hookworm infection in pregnancy. Trans. R. Soc. Trop. Med. Hyg. 89 (1995) 521-522
22. Christian P., et al. Antenatal anthelmintic treatment, birthweight, and infant survival. Lancet 364 (2004) 981-983
23. Allen H.E., et al. New policies for using anthelmintics in high risk groups. Trends Parasitol. 18 (2002) 381-382
24. World Health Organization (2002) Prevention and Control Of Schistosomiasis and Soil-Transmitted Helminthiasis. Report of a WHO expert committee. WHO Technical Report Series 912, p. 35, World Health Organization
25. Raso G., et al. Multiple parasite infections and their relationship to self-reported morbidity in a community of rural Cote d'Ivoire. Int. J. Epidemiol. 33 (2004) 1092-1102
26. Molyneux D.H., et al. "Rapid-impact interventions": how a policy of integrated control of Africa's neglected tropical diseases could benefit the poor. PLoS Med 2 (2005) e336
27. Hotez P.J., et al. Incorporating a rapid impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis and malaria, a comprehensive pro-poor health policy and strategy for the developing world. PLoS Med 3 (2006) e102
28. Druilhe P., et al. Worms can worsen malaria: towards a new means to roll back malaria?. Trends Parasitol. 21 (2005) 359-362
29. Bundy D., et al. Good worms or bad worms: do worm infections affect the epidemiological patterns of other diseases. Parasitol. Today 16 (2000) 273-274
30. Borkow G., and Bentwich Z. Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy. Clin. Microbiol. Rev. 17 (2004) 1012-1030
31. Gallagher M., et al. The effects of maternal helminth and malaria infections on mother-to-child HIV transmission. AIDS 19 (2005) 1849-1855
32. Shapiro A.E., et al. Epidemiology of helminth infections and their relationship to clinical malaria in southwest Uganda. Trans. R. Soc. Trop. Med. Hyg. 99 (2005) 18-24
33. Brown M., et al. Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda. J. Infect. Dis. 190 (2004) 1869-1879
34. Chan M.S., et al. Transmission patterns and the epidemiology of hookworm infection. Int. J. Epidemiol. 26 (1997) 1392-1400
35. Bennett A., and Guyatt H. Reducing intestinal nematode infection: efficacy of albendazole and mebendazole. Parasitol. Today 16 (2000) 71-74
36. Albonico M., et al. Rate of reinfection with intestinal nematodes after treatment of children with mebendazole or albendazole in a highly endemic area. Trans. R. Soc. Trop. Med. Hyg. 89 (1995) 538-541
37. Albonico M., et al. Efficacy of mebendazole and levamisole alone or in combination against intestinal nematode infections after repeated targeted mebendazole treatment in Zanzibar. Bull. World Health Organ. 81 (2003) 343-352
38. Albonico M., et al. Monitoring drug efficacy and early detection of drug resistance in human soil-transmitted nematodes: a pressing public health agenda for helminth control. Int. J. Parasitol. 34 (2004) 1205-1210
39. Utzinger J., and Keiser J. Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control. Expert Opin. Pharmacother. 5 (2004) 263-286
40. Xiao S.H., et al. Tribendimidine: a promising, safe and broad-spectrum anthelmintic agent from China. Acta Trop. 94 (2005) 1-14
41. Miller T.A. Industrial development and field use of the canine hookworm vaccine. Adv. Parasitol. 16 (1978) 333-342
42. Cort W.W., and Otto G.F. Immunity in hookworm disease. Rev. Gastroenterol. 7 (1940) 2-14
43. Hotez P.J., et al. Progress in the development of a recombinant vaccine for human hookworm disease: the Human Hookworm Vaccine Initiative. Int. J. Parasitol. 33 (2003) 1245-1258
44. Hawdon J.M., et al. Cloning and characterization of Ancylostoma secreted protein. A novel protein associated with the transition to parasitism by infective hookworm larvae. J. Biol. Chem. 271 (1996) 6672-6678
45. Hawdon J.M., et al. Ancylostoma secreted protein 2: cloning and characterization of a second member of a family of nematode secreted proteins from Ancylostoma caninum. Mol. Biochem. Parasitol. 99 (1999) 149-165
46. Asojo O.A., et al. X-ray structure of Na-ASP-2, a pathogenesis-related-1 protein from the nematode parasite, Necator americanus, and a vaccine antigen for human hookworm infection. J. Mol. Biol. 346 (2005) 801-814
47. Fujiwara R.T., et al. Vaccination with irradiated Ancylostoma caninum third stage larvae induces a Th2 protective response in dogs. Vaccine 24 (2005) 501-509
48. Bethony J., et al. Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animals. FASEB J. 19 (2005) 1743-1745
49. Goud G.N., et al. Cloning, yeast expression, isolation, and vaccine testing of recombinant Ancylostoma secreted protein (ASP)-1 and ASP-2 from Ancylostoma ceylanicum. J. Infect. Dis. 189 (2004) 919-929
50. Mendez S., et al. Effect of combining the larval antigens Ancylostoma secreted protein 2 (ASP-2) and metalloprotease 1 (MTP-1) in protecting hamsters against hookworm infection and disease caused by Ancylostoma ceylanicum. Vaccine 23 (2005) 3123-3130
51. Goud G.N., et al. Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials. Vaccine 23 (2005) 4754-4764
52. Brooker S., et al. Epidemiologic, immunologic and practical considerations in developing and evaluating a human hookworm vaccine. Expert Rev. Vaccines 4 (2005) 35-50
53. Williamson A., et al. Cleavage of hemoglobin by hookworm cathepsin D aspartic proteases and its potential contribution to host specificity. FASEB J. 16 (2002) 1458-1460
54. Williamson A., et al. A multi-enzyme cascade of hemoglobin proteolysis in the intestine of blood-feeding hookworms. J. Biol. Chem. 279 (2004) 35950-35957
55. Loukas A., et al. Vaccination with recombinant aspartic hemoglobinase reduces parasite load and protects against anemia after challenge infection with blood-feeding hookworms. PLoS Med 2 (2005) e295
56. Morel C.M., et al. Health innovation networks to help developing countries address neglected diseases. Science 309 (2005) 401-404
57. Salunkhe D.S., et al. Clinical evaluation of a new anthelmintic thiabendazole (2-(4′-thiazolyl)-benzimidazole). Am. J. Trop. Med. Hyg. 13 (1964) 412-416
58. Horton J. Albendazole: a broad spectrum anthelmintic for treatment of individuals and populations. Curr. Opin. Infect. Dis. 15 (2002) 599-608
59. Banerjee D., et al. A clinical trial of mebendazole (R17,635) in cases of hookworm infection. Indian J. Med. Res. 60 (1972) 562-566
60. Kates K.C., et al. Experimental development of a cambendazole-resistant strain of Haemonchus contortus in sheep. J. Parasitol. 59 (1973) 169-174
61. Hotez P.J., et al. Hookworm antigens: the potential for vaccination. Parasitol. Today 3 (1987) 247-249
62. Carr A., and Pritchard D.I. Antigen expression during development of the human hookworm, Necator americanus (Nematoda). Parasite Immunol. 9 (1987) 219-234
63. Harrop S.A., et al. Acasp, a gene encoding a cathepsin D-like aspartic protease from the hookworm Ancylostoma caninum. Biochem. Biophys. Res. Commun. 227 (1996) 294-302
64. Murray C.J., et al. The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull. World Health Organ. 72 (1994) 495-509